Report Description

India cefoperazone market is expected to grow at a steady rate during the forecast period. The India cefoperazone market is driven by increasing cases of bacterial infections in patients.  Favourable policies implemented by the government of the country for the manufacturing and development of drugs, intermediates, and active pharmaceutical ingredients is forecasted to positively influence the market growth. Also, cefoperazone is used to treat respiratory tract infections which are caused by S. pneumoniae, H. influenzae, S. aureus, and other susceptible species which is further expected to boost the demand through FY2026.

The India cefoperazone market is segmented based on composition, route of administration, source, distribution channel, application, end user, company, and region. Based on route of administration, the market can be segmented into intramuscular and intravenous. The intravenous route of administration is expected to dominate the market in the coming years on account of certain advantages such as the drug response is very rapid, and the dosage of the drug can be easily controlled. Furthermore, intravenous route of administration is much useful in situations of poor gastrointestinal absorption, which is further forecasted to contribute to the growth of segment.

The major players operating in the India cefoperazone market are Sterile India Private Ltd., Alkem Laboratories Ltd., Aurobindo Pharma Ltd., Bennet Pharmaceuticals Ltd., Tauras Laboratories Pvt. Ltd., Winsome Laboratories Ltd., Venus Remedies Ltd., Taj Pharmaceuticals Ltd., ELIS Pharmaceuticals (India) Pvt. Ltd., Cadila Pharmaceuticals Ltd, and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India cefoperazone market from FY2016 to FY2019.
  • To estimate and forecast the market size of India cefoperazone market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India cefoperazone market based on composition, route of administration, source, distribution channel, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the India cefoperazone market.
  • To identify drivers and challenges for India cefoperazone market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India cefoperazone market.
  • To identify and analyze the profile of leading players operating in India cefoperazone market.
  • To identify key sustainable strategies adopted by market players in India cefoperazone market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India cefoperazone market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Cefoperazone manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to cefoperazone

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India cefoperazone market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Cefoperazone Market, By Composition:
    • Single
    • Combinational
  • India Cefoperazone Market, By Route of Administration:
    • Intramuscular
    • Intravenous
  • India Cefoperazone Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Cefoperazone Market, By Distribution Channel:
    • Online
    • Offline
  • India Cefoperazone Market, By Application:
    • Bacterial Infections
    • Respiratory Infections
    • Skin Infections
    • Urinary Infections
    • Others
  • India Cefoperazone Market, By End User:
    • Adult
    • Paediatric
  • India Cefoperazone Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India cefoperazone market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India cefoperazone market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Cefoperazone Market

4.    Executive Summary

5.    Manufacturing Cefoperazone

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Cefoperazone

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Cefoperazone Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Composition (Single, Combinational)

7.2.2.     By Route of Administration (Intramuscular v/s Intravenous)

7.2.3.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.4.     By Distribution Channel (Online v/s Offline)

7.2.5.     By Application (Bacterial Infections, Respiratory Infections, Skin Infections, Urinary Infections, Others)

7.2.6.     By End User (Adult v/s Paediatric)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Sterile India Private Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Alkem Laboratories Ltd.

14.1.3.  Aurobindo Pharma Ltd.

14.1.4.  Bennet Pharmaceuticals Ltd.

14.1.5.  Tauras Laboratories Pvt. Ltd.

14.1.6.  Winsome Laboratories Ltd.

14.1.7.  Venus Remedies Ltd.

14.1.8.  Taj Pharmaceuticals Ltd.

14.1.9.  ELIS Pharmaceuticals (India) Pvt. Ltd.

14.1.10.                Cadila Pharmaceuticals Ltd.

15.  Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions






Sakshi Bajaal

Business Consultant
Press Release

India Cefoperazone Market to grow at a steady rate During the Forecast Period

Oct, 2020

Growing prevalence of bacterial infections is expected to drive the growth of India cefoperazone market during the forecast period.